Chemoinformaics analysis of (3Z,6Z,9Z)-DODECATRIENOL
| Molecular Weight | 180.291 | nRot | 7 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 3 |
| Exact Molecular Weight | 180.151 | nRing | 0 |
| Solubility: LogS | -2.93 | nHRing | 0 |
| Solubility: LogP | 3.598 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 34.1779 |
| nHD | 1 | BPOL | 20.0641 |
| QED | 0.596 |
| Synth | 2.989 |
| Natural Product Likeliness | 1.873 |
| NR-PPAR-gamma | 0.343 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.032 |
| HIA | 0.005 |
| CACO-2 | -4.398 |
| MDCK | 0.000117095 |
| BBB | 0.879 |
| PPB | 0.695998 |
| VDSS | 0.947 |
| FU | 0.212026 |
| CYP1A2-inh | 0.585 |
| CYP1A2-sub | 0.152 |
| CYP2c19-inh | 0.073 |
| CYP2c19-sub | 0.072 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.81 |
| CYP2d6-inh | 0.014 |
| CYP2d6-sub | 0.196 |
| CYP3a4-inh | 0.265 |
| CYP3a4-sub | 0.114 |
| CL | 12.898 |
| T12 | 0.801 |
| hERG | 0.003 |
| Ames | 0.651 |
| ROA | 0.003 |
| SkinSen | 0.964 |
| Carcinogencity | 0.364 |
| EI | 0.994 |
| Respiratory | 0.481 |
| NR-Aromatase | 0.015 |
| Antiviral | No |
| Prediction | 0.713924 |